Plante Moran Financial Advisors’s West Pharmaceutical WST Stock Holding History

Plante Moran Financial Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.1K	Buy	+17	New	+$5.2K	﹤0.01%	618
2022 Q3	–	Sell	-15	Closed	-$5K	–	1094
2022 Q2	$5K	Buy	+15	New	+$4.88K	﹤0.01%	729
2022 Q1	–	Sell	-15	Closed	-$7K	–	1027
2021 Q4	$7K	Sell	15 -25	-63%	-$10.8K	﹤0.01%	766
2021 Q3	$17K	Buy	+40	New	+$16.9K	﹤0.01%	600
2018 Q3	–	Sell	-10	Closed	-$1K	–	852
2018 Q2	$1K	Buy	10 +4	+67%	+$368	﹤0.01%	784
2018 Q1	$1K	Sell	6 -3	-33%	-$281	﹤0.01%	924
2017 Q4	$1K	Buy	9 +3	+50%	+$294	﹤0.01%	850
2017 Q3	$1K	Hold	6	–	–	﹤0.01%	786
2017 Q2	$1K	Hold	6	–	–	﹤0.01%	805
2017 Q1	$0	Buy	+6	New	+$502	﹤0.01%	1051
2015 Q3	–	Sell	-1,000	Closed	-$58K	–	757
2015 Q2	$58K	Buy	+1,000	New	+$55.8K	0.04%	271

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Plante Moran Financial Advisors's WST Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in West Pharmaceutical (WST) in Q2 2026: 17 shares worth $6.1K. The stake represents ﹤0.01% of the portfolio and ranks #618 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in WST as recently as Q2 2022.

Plante Moran Financial Advisors first reported a position in WST in Q2 2015 and has held it in 11 quarters since. The position peaked at $58K in Q2 2015. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Plante Moran Financial Advisors held 17 shares of West Pharmaceutical worth $6.1K as of Q2 2026.
West Pharmaceutical was a new Plante Moran Financial Advisors position in Q2 2026.
West Pharmaceutical made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #618 holding.
Plante Moran Financial Advisors first reported a position in West Pharmaceutical in Q2 2015 and has held it in 11 quarters since.
Plante Moran Financial Advisors's West Pharmaceutical position peaked at $58K in Q2 2015.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.